Moscow, Russia

Jury Mikhailovich Luzhkov

This inventor holds 1 USPTO granted patent. Top assignees: Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik', Institut Elementoorganicheskikh Soedineny Rossiiskoi Akademii Nauk, Moskovsky Naucho-Issledovatelsky Onkologichesky Institut. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jury Mikhailovich Luzhkov. Retrieved from https://idiyas.com/inventor/jury-mikhailovich-luzhkov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Jury Mikhailovich Luzhkov: A Pioneer in Tumor Growth Suppression**

Introduction

Jury Mikhailovich Luzhkov, based in Moscow, Russia, is recognized for his innovative contributions to the field of cancer research. With a focus on developing agents that can suppress tumor growth, Luzhkov has made significant strides in medical science.

Latest Patents

He holds a notable patent for an "Agent for Suppressing Tumor Growth." This invention highlights his dedication to advancing cancer treatment methods and showcases his role as an inventor committed to battling this critical health challenge.

Career Highlights

Luzhkov has worked with esteemed institutions such as the Institute of Element-Organic Compounds of the Russian Academy of Sciences and the State Scientific Center of the Russian Federation "NIOPIK." His tenure at these organizations has provided him with a platform to innovate and contribute to significant scientific advancements.

Collaborations

During his career, Luzhkov has collaborated with distinguished peers, including Mark Efimovich Volpin, who is now deceased, and Georgy Nikolaevich Vorozhtsov. These collaborations have enriched his research endeavors and fostered a creative exchange of ideas in the scientific community.

Conclusion

Jury Mikhailovich Luzhkov's work and dedication to suppressing tumor growth place him among the noteworthy inventors in the medical field. His singular patent continues to reflect his commitment to innovation and the pursuit of advancements that can ultimately improve patient outcomes in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…